Difficulty: Medium

Average Score: 67%

Which of the following statements is true concerning a product that has a Risk Evaluation and Mitigation Strategy (REMS) program?

Rationale

The product would not be on the market without a REMS program due to patient safety concerns.

A Risk Evaluation and Mitigation Strategy (REMS) is required by the FDA for certain drugs to ensure that their benefits outweigh the risks associated with their use. The presence of a REMS program indicates that the product has been assessed to pose specific risks that necessitate additional safety measures before it can be marketed.

A (Compounding the product must be done according to instructions found in the REMS program) YOUR ANSWER

While the REMS program may include specific guidelines for safe usage, it does not govern the compounding of the product itself. Compounding is typically regulated by different standards and is not inherently linked to REMS requirements, which focus on risk management rather than compounding practices.

B (A product with a REMS program is more likely to be involved in misuse or diversion) YOUR ANSWER

This statement misrepresents the purpose of a REMS program. REMS are implemented to manage risks and ensure safe use, not to indicate that a product is more likely to be misused or diverted. Rather, they aim to mitigate potential misuse through careful distribution and patient education.

C (Whether to adhere to the product's REMS program guidelines is determined by pharmacist discretion) YOUR ANSWER

Adhering to REMS guidelines is not at the discretion of individual pharmacists; it is a requirement for safe dispensing and use of the product. Pharmacists must follow established REMS protocols to ensure compliance with regulatory standards and protect patient safety.

Conclusion

The necessity of a REMS program signifies that a product poses risks requiring stringent management before it can be marketed, emphasizing the FDA's commitment to patient safety. Therefore, the presence of a REMS program is essential for bringing certain drugs to market, ensuring that the benefits are balanced with necessary precautions to mitigate risks.

Related Questions

View all